Active surveillance of serious adverse events following transfusion of COVID ‐19 convalescent plasma-Reference-Cited by-同舟云学术

Active surveillance of serious adverse events following transfusion of COVID ‐19 convalescent plasma

Published:2021-10-22 Issue:1 Volume:62 Page:28-36
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Swenson Erica¹^ORCID,Wong Lisa Kanata¹^ORCID,Jhaveri Perrin²,Weng Yingjie³,Kappagoda Shanthi⁴,Pandey Suchitra¹⁵^ORCID,Pritchard Angelica⁶^ORCID,Rogers Angela⁷,Ruoss Stephen⁷,Subramanian Aruna⁴,Shan Hua¹,Hollenhorst Marie¹⁸⁹^ORCID

Affiliation:

1. Department of Pathology Stanford University Stanford California USA

2. Department of Hematology Kaiser Permanente Renton Washington USA

3. Department of Medicine, Quantitative Sciences Unit Stanford University Stanford California USA

4. Department of Medicine, Division of Infectious Diseases and Geographic Medicine Stanford University Stanford California USA

5. Stanford Blood Center Stanford California USA

6. Department of Emergency Medicine Stanford University Stanford California USA

7. Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine Stanford University Stanford California USA

8. Department of Medicine, Division of Hematology Stanford University Stanford California USA

9. Chemistry, Engineering, & Medicine for Human Health Institute (ChEM‐H) Stanford University Stanford California USA

Funder

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16711

Reference24 articles.

1. International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection

2. COVID-19 Convalescent Plasma: Now Is the Time for Better Science

3. Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression

4. Adverse effects of plasma transfusion

5. TACO‐BEL‐3: a feasibility study and a retrospective audit of diuretics for patients receiving blood transfusion at ten hospitals

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge;Transplant Infectious Disease;2023-03-16

2. COVID-19 convalescent plasma: current status, lessons from the past and future perspectives;Transfusion and Apheresis Science;2022-08

3. Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee;Transfusion;2022-06-17